Published in Heart Int on June 19, 2012
A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med (1999) 82.86
Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2008) 15.35
ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med (2003) 8.83
Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation (1991) 4.89
Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation (1997) 4.61
Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol (2005) 4.26
Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation (2004) 3.56
Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol (2001) 3.14
Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. J Am Coll Cardiol (2005) 2.34
Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. J Am Soc Nephrol (2002) 1.93
Diagnosis of heart failure using urinary natriuretic peptides. Clin Sci (Lond) (2004) 1.62
Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial. Circulation (2004) 1.59
Renal dysfunction, as measured by the modification of diet in renal disease equations, and outcome in patients with advanced heart failure. Eur Heart J (2007) 1.57
Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure. J Am Coll Cardiol (2002) 1.47
The prognostic value of estimated creatinine clearance alongside functional capacity in ambulatory patients with chronic congestive heart failure. J Am Coll Cardiol (2002) 1.34
Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review. Eur Heart J (2008) 1.32
Relation of oxygen uptake to work rate in normal men and men with circulatory disorders. Am J Cardiol (1987) 1.25
Elimination of the cardiac natriuretic peptides B-type natriuretic peptide (BNP) and N-terminal proBNP by hemodialysis. Clin Chem (2004) 1.25
The prognostic role of brain natriuretic peptides in hemodialysis patients. Am J Nephrol (2002) 1.10
Ethnicity and renal disease: lessons from the Multiple Risk Factor Intervention Trial and the Treatment of Mild Hypertension Study. Am J Kidney Dis (1993) 1.03
Plasma brain natriuretic peptide levels in chronic hemodialysis patients: influence of coronary artery disease. Am J Kidney Dis (2001) 0.97
Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease. Am J Cardiol (2008) 0.95
Cardiopulmonary responses to exercise in patients with hypertrophic cardiomyopathy. Heart (1998) 0.85
Significance of brain natriuretic peptides in patients on continuous ambulatory peritoneal dialysis. Int J Mol Med (2002) 0.83
Circulating N-terminal pro-brain natriuretic peptide and cardiac troponin T in chronic dialysis patients. J Med Assoc Thai (2003) 0.77
Clinical relevance of cardiac natriuretic peptides measured by means of competitive and non-competitive immunoassay methods in patients with renal failure on chronic hemodialysis. J Endocrinol Invest (2001) 0.77
Mechanical ventilation with lower tidal volumes and positive end-expiratory pressure prevents alveolar coagulation in patients without lung injury. Anesthesiology (2006) 2.19
Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation (2011) 1.92
Local activation of the tissue factor-factor VIIa pathway in patients with pneumonia and the effect of inhibition of this pathway in murine pneumococcal pneumonia. Crit Care Med (2006) 1.82
Right ventricular failure following chronic pressure overload is associated with reduction in left ventricular mass: evidence for atrophic remodeling. J Am Coll Cardiol (2011) 1.74
Mechanical ventilation with lower tidal volumes and positive end-expiratory pressure prevents pulmonary inflammation in patients without preexisting lung injury. Anesthesiology (2008) 1.63
A novel echocardiographic predictor of in-hospital mortality and mid-term haemodynamic improvement after pulmonary endarterectomy for chronic thrombo-embolic pulmonary hypertension. Eur Heart J (2007) 1.62
Antiinflammatory effects of salmeterol after inhalation of lipopolysaccharide by healthy volunteers. Am J Respir Crit Care Med (2005) 1.60
Antithrombin inhibits bronchoalveolar activation of coagulation and limits lung injury during Streptococcus pneumoniae pneumonia in rats. Crit Care Med (2008) 1.58
Activation of coagulation and inhibition of fibrinolysis in the human lung on bronchial instillation of lipoteichoic acid and lipopolysaccharide. Crit Care Med (2009) 1.55
Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology. Eur J Nucl Med Mol Imaging (2010) 1.49
Electrophysiologic remodeling of the left ventricle in pressure overload-induced right ventricular failure. J Am Coll Cardiol (2012) 1.44
Longitudinal follow-up of six-minute walk distance after pulmonary endarterectomy. Ann Thorac Surg (2011) 1.42
Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review. Eur Heart J (2008) 1.32
Ventilator-induced lung injury is mediated by the NLRP3 inflammasome. Anesthesiology (2012) 1.21
Lung epithelial injury markers are not influenced by use of lower tidal volumes during elective surgery in patients without preexisting lung injury. Am J Physiol Lung Cell Mol Physiol (2007) 1.19
Pulmonary endarterectomy improves dyspnea by the relief of dead space ventilation. Ann Thorac Surg (2010) 1.18
Influence of collimator choice and simulated clinical conditions on 123I-MIBG heart/mediastinum ratios: a phantom study. Eur J Nucl Med Mol Imaging (2005) 1.16
Reverse right ventricular remodeling after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension: utility of magnetic resonance imaging to demonstrate restoration of the right ventricle. J Thorac Cardiovasc Surg (2007) 1.15
Embolization for hemoptysis in chronic thromboembolic pulmonary hypertension: report of two cases and a review of the literature. Cardiovasc Intervent Radiol (2006) 1.14
Plasminogen activator inhibitor type-1 deficiency does not influence the outcome of murine pneumococcal pneumonia. Blood (2003) 1.14
Brain natriuretic peptide as noninvasive marker of the severity of right ventricular dysfunction in chronic thromboembolic pulmonary hypertension. Ann Thorac Surg (2007) 1.11
Systemic and local high mobility group box 1 concentrations during severe infection. Crit Care Med (2007) 1.10
Lung inflammation induced by lipoteichoic acid or lipopolysaccharide in humans. Am J Respir Crit Care Med (2008) 1.09
Pulmonary function impairment measured by pulmonary function tests in long-term survivors of childhood cancer. Thorax (2011) 1.08
Six-minute walk distance as parameter of functional outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. J Thorac Cardiovasc Surg (2007) 1.07
Molecular and cellular basis for diastolic dysfunction. Curr Heart Fail Rep (2012) 1.05
Antibiotics and steroids for exacerbations of COPD in primary care: compliance with Dutch guidelines. Br J Gen Pract (2006) 1.01
Activation of neutrophils and inhibition of the proinflammatory cytokine response by endogenous granulocyte colony-stimulating factor in murine pneumococcal pneumonia. J Infect Dis (2004) 1.00
Protease-activated receptor-2 induces myofibroblast differentiation and tissue factor up-regulation during bleomycin-induced lung injury: potential role in pulmonary fibrosis. Am J Pathol (2010) 0.95
Vascular malformations as underlying cause of chronic thromboembolism and pulmonary hypertension. J Plast Reconstr Aesthet Surg (2008) 0.94
Chronic pulmonary embolism in Klippel-Trenaunay syndrome. J Am Acad Dermatol (2011) 0.94
Endogenous MCP-1 promotes lung inflammation induced by LPS and LTA. Mol Immunol (2011) 0.93
Recombinant human activated protein C inhibits local and systemic activation of coagulation without influencing inflammation during Pseudomonas aeruginosa pneumonia in rats. Crit Care Med (2007) 0.93
Impact of mediastinal, liver and lung (123)I-metaiodobenzylguanidine ( (123)I-MIBG) washout on calculated (123)I-MIBG myocardial washout. Eur J Nucl Med Mol Imaging (2009) 0.92
Pulmonary endarterectomy normalizes interventricular dyssynchrony and right ventricular systolic wall stress. J Cardiovasc Magn Reson (2012) 0.91
Activation of coagulation and inhibition of fibrinolysis in the lung after inhalation of lipopolysaccharide by healthy volunteers. Thromb Haemost (2005) 0.91
Gene expression profiles in alveolar macrophages induced by lipopolysaccharide in humans. Mol Med (2012) 0.89
Effect of bosentan on exercise capacity and quality of life in adults with pulmonary arterial hypertension associated with congenital heart disease with and without Down's syndrome. Am J Cardiol (2009) 0.89
Hemodynamic and clinical correlates of endothelin-1 in chronic thromboembolic pulmonary hypertension. Circ J (2006) 0.88
Salmeterol enhances pulmonary fibrinolysis in healthy volunteers. Crit Care Med (2007) 0.88
Time course of restoration of systolic and diastolic right ventricular function after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Am Heart J (2011) 0.87
Exaggerated IL-8 and IL-6 responses to TNF-alpha by parainfluenza virus type 4-infected NCI-H292 cells. Am J Physiol Lung Cell Mol Physiol (2004) 0.87
Bosentan as a bridge to pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. J Thorac Cardiovasc Surg (2009) 0.86
Fibrotic idiopathic interstitial pneumonias: mortality is linked to a decline in gas transfer. Respirology (2010) 0.86
Bosentan treatment is associated with improvement of right ventricular function and remodeling in chronic thromboembolic pulmonary hypertension. Clin Cardiol (2013) 0.85
Pulmonary function vascular index predicts prognosis in idiopathic interstitial pneumonia. Respirology (2012) 0.85
Plasma brain natriuretic peptide as a biomarker for haemodynamic outcome and mortality following pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Interact Cardiovasc Thorac Surg (2012) 0.85
Priming of alveolar macrophages upon instillation of lipopolysaccharide in the human lung. Am J Respir Cell Mol Biol (2009) 0.85
Exercise tolerance, lung function abnormalities, anemia, and cardiothoracic ratio in sickle cell patients. Am J Hematol (2014) 0.84
Clinical performance and radiation dosimetry of no-carrier-added vs carrier-added 123I-metaiodobenzylguanidine (MIBG) for the assessment of cardiac sympathetic nerve activity. Eur J Nucl Med Mol Imaging (2008) 0.82
Active search for chronic thromboembolic pulmonary hypertension does not appear indicated after acute pulmonary embolism. Thromb Res (2010) 0.82
Early procoagulant shift in the bronchoalveolar compartment of patients with secondary peritonitis. J Infect Dis (2006) 0.81
Chorea in adults after pulmonary endarterectomy with deep hypothermia and circulatory arrest. Ann Intern Med (2008) 0.80
No-carrier-added versus carrier-added123I-metaiodobenzylguanidine for the assessment of cardiac sympathetic nerve activity. Eur J Nucl Med Mol Imaging (2006) 0.80
Compartmental apoptosis and neutrophil accumulation in severe peritonitis. J Surg Res (2009) 0.80
Decreased plasma neurohormones and improved cardiac performance after surgical treatment of chronic pulmonary embolism. Ann Thorac Surg (2003) 0.79
Stress-related variations in left ventricular function as assessed with gated myocardial perfusion SPECT. J Nucl Cardiol (2003) 0.79
Pulmonary arterial stent implantation in an adult with Williams syndrome. Cardiovasc Intervent Radiol (2007) 0.79
Vascular time-activity variation in patients undergoing ¹²³I-MIBG myocardial scintigraphy: implications for quantification of cardiac and mediastinal uptake. Eur J Nucl Med Mol Imaging (2011) 0.79
Comparison between tagged MRI and standard cine MRI for evaluation of left ventricular ejection fraction. Eur Radiol (2004) 0.78
Manual hyperinflation partly prevents reductions of functional residual capacity in cardiac surgical patients--a randomized controlled trial. Crit Care (2011) 0.78
[Fatal tuberculosis during treatment with ruxolitinib]. Ned Tijdschr Geneeskd (2015) 0.78
Persisting myocardial sympathetic dysfunction in takotsubo cardiomyopathy. J Nucl Cardiol (2009) 0.77
Tako-tsubo cardiomyopathy: how to understand possible pathophysiological mechanism and the role of (123)I-MIBG imaging. J Nucl Cardiol (2014) 0.77
Intrabronchial activated protein C enhances lipopolysaccharide-induced pulmonary responses. Eur Respir J (2012) 0.77
TLR2 deficiency aggravates lung injury caused by mechanical ventilation. Shock (2014) 0.77
123I-meta-iodobenzylguanidine in patients with chronic heart failure: technical aspects, conceptual issues, and future prospects. Nucl Med Commun (2009) 0.77
Right-to-left ventricular diastolic delay in chronic thromboembolic pulmonary hypertension is associated with activation delay and action potential prolongation in right ventricle. Circ Arrhythm Electrophysiol (2009) 0.77
Duration of right ventricular contraction predicts the efficacy of bosentan treatment in patients with pulmonary hypertension. Eur J Echocardiogr (2008) 0.77
Mechanisms for cardiac output augmentation in patients with a systemic right ventricle. Int J Cardiol (2009) 0.76
Impact of a predefined mediastinal ROI on inter-observer variability of planar ¹²³I-MIBG heart-to-mediastinum ratio. J Nucl Cardiol (2014) 0.76
Semiquantitative 67Ga scintigraphy as an indicator of response to and prognosis after corticosteroid treatment in idiopathic interstitial pneumonia. J Nucl Med (2005) 0.76
New strains of bacteria and exacerbations of COPD. N Engl J Med (2002) 0.75
Need for additional information and diagnostic tools in navigation of the lung? Chest (2009) 0.75
The receptor for advanced glycation end products in ventilator-induced lung injury. Intensive Care Med Exp (2014) 0.75
Bosentan in mild pulmonary hypertension. Lancet (2008) 0.75
Extensive slow-flow vascular malformations and pulmonary hypertension. Arch Dermatol (2010) 0.75
Renal Function in Relation to Cardiac (123)I-MIBG Scintigraphy in Patients with Chronic Heart Failure. Int J Mol Imaging (2012) 0.75
The use of perfusion scintigraphy to differentiate proximal right coronary artery stenosis from distal right coronary artery stenosis in patients with inferior left ventricular ischaemia. Nucl Med Commun (2007) 0.75
Mechanisms that potentially underlie virus-induced exaggerated inflammatory responses by airway epithelial cells. Chest (2003) 0.75
[Chronic thrombo-embolic pulmonary hypertension]. Ned Tijdschr Geneeskd (2010) 0.75
[Idiopathic pulmonary fibrosis: new insights]. Ned Tijdschr Geneeskd (2015) 0.75
[A paradox: sarcoidosis in an HIV-positive patient]. Ned Tijdschr Geneeskd (2015) 0.75
[Are we on the verge of lung-cancer screening in the Netherlands?]. Ned Tijdschr Geneeskd (2015) 0.75
Differential effects of nonselective versus selective β-blockers on cardiac sympathetic activity and hemostasis in patients with heart failure. J Nucl Med (2013) 0.75
Chorea in adults following pulmonary endarterectomy. Mov Disord (2010) 0.75